Ownership history in Squarepoint Ops LLC · 10 quarters on record
This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in NURIX THERAPEUTICS INC (NRIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 28,784 | -47,688 | -62.4% | 0.00% | $266K | $9.24 |
| 2025 Q2 | REDUCED | 76,472 | -8,154 | -9.6% | 0.00% | $871K | $11.39 |
| 2025 Q1 | ADDED | 84,626 | +7,992 | +10.4% | 0.00% | $1.0M | $11.88 |
| 2024 Q4 | ADDED | 76,634 | +9,354 | +13.9% | 0.00% | $1.4M | $18.84 |
| 2024 Q3 | ADDED | 67,280 | +38,496 | +133.7% | 0.00% | $1.5M | $22.47 |
| 2024 Q2 | ADDED | 28,784 | +8,268 | +40.3% | 0.00% | $601K | $20.87 |
| 2022 Q1 | ADDED | 20,516 | +4,370 | +27.1% | 0.00% | $287K | $14.01 |
| 2021 Q4 | ADDED | 16,146 | +5,588 | +52.9% | 0.00% | $467K | $28.95 |
| 2021 Q2 | REDUCED | 10,558 | -5,250 | -33.2% | 0.00% | $280K | $26.53 |
| 2021 Q1 | INITIATED | 15,808 | — | — | 0.00% | $491K | $31.09 |
As of 2025 Q4 — sorted by position size